The 42nd annual J.P. Morgan Healthcare Conference started with clear skies and overall optimism from investors. But with Jamie Dimon’s prediction of a recession in 2024 on Tuesday morning, the climate shifted to an on-again,...more
1/12/2024
/ Acquisitions ,
Asset Diversification ,
Chapter 11 ,
Health Technology ,
Healthcare ,
Home Health Care ,
Hospice ,
Initial Public Offering (IPO) ,
Investors ,
JPMorgan Chase ,
Medicaid ,
Mental Health ,
Mergers ,
Pharmaceutical Industry ,
Reimbursements ,
Takeovers ,
Value-Based Care
Discover the factors that drove healthcare M&A activity in 2019.
Innovation, expansion and continued private equity investment in the industry influenced healthcare transactions last year. 2019 saw continued robust...more
1/16/2020
/ Acquisitions ,
Ambulatory Surgery Centers ,
Centers for Medicare & Medicaid Services (CMS) ,
Divestiture ,
EBITDA ,
Health Care Providers ,
Health Information Technologies ,
Healthcare Facilities ,
Home Health Care ,
Hospice ,
Hospitals ,
Joint Venture ,
Managed Care Contracts ,
Medicare ,
Medicare Advantage ,
Mental Health ,
Mergers ,
Pharmacies ,
Physicians ,
Private Equity ,
Private Equity Firms
Healthcare transactional activity continued unabated throughout 2016, continuing a years long trend of sustained growth. This activity is due to a number of factors: innovative technology, pharmaceuticals, and services that...more
1/9/2017
/ Addiction Equity Act ,
Health Care Providers ,
Health IT ,
Healthcare Facilities ,
Hospitals ,
Industry Consolidation ,
Innovation ,
Managed Care Contracts ,
Medicare Access and CHIP Reauthorization (MACRA) ,
Mental Health ,
Pharmaceutical Industry ,
Pharmacies ,
Physicians ,
Provider Payments